Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5EY9

Structure of FadD32 from Mycobacterium marinum complexed to AMPC12

Summary for 5EY9
Entry DOI10.2210/pdb5ey9/pdb
DescriptorLong-chain-fatty-acid--AMP ligase FadD32, [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl icosyl hydrogen phosphate, GLYCEROL, ... (4 entities in total)
Functional Keywordsligase, fatty-acyl amp ligase
Biological sourceMycobacterium marinum
Total number of polymer chains2
Total formula weight139843.10
Authors
Guillet, V.,Maveyraud, L.,Mourey, L. (deposition date: 2015-11-24, release date: 2015-12-16, Last modification date: 2024-01-10)
Primary citationGuillet, V.,Galandrin, S.,Maveyraud, L.,Ladeveze, S.,Mariaule, V.,Bon, C.,Eynard, N.,Daffe, M.,Marrakchi, H.,Mourey, L.
Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.
J.Biol.Chem., 291:7973-7989, 2016
Cited by
PubMed Abstract: Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is one of the targets of first-line antituberculous drugs. This pathway contains a number of potential targets, including some that have been identified only recently and have yet to be explored. One such target, FadD32, is required for activation of the long meromycolic chain and is essential for mycobacterial growth. We report here an in-depth biochemical, biophysical, and structural characterization of four FadD32 orthologs, including the very homologous enzymes fromMycobacterium tuberculosisandMycobacterium marinum Determination of the structures of two complexes with alkyl adenylate inhibitors has provided direct information, with unprecedented detail, about the active site of the enzyme and the associated hydrophobic tunnel, shedding new light on structure-function relationships and inhibition mechanisms by alkyl adenylates and diarylated coumarins. This work should pave the way for the rational design of inhibitors of FadD32, a highly promising drug target.
PubMed: 26900152
DOI: 10.1074/jbc.M115.712612
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon